Order Article Reprints

Leroux-Roels I, Day TA, Deleu S, McLean C, Go O, Davies TA, Stoop JN, Peeters M, Pau MG, Spiessens B, et al. Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines. 2026; 14(2):146. https://doi.org/10.3390/vaccines14020146

Leroux-Roels, Isabel, Tracey A. Day, Sofie Deleu, Chelsea McLean, Oscar Go, Todd A. Davies, Jeroen N. Stoop, Monika Peeters, Maria G. Pau, Bart Spiessens, and et al. 2026. "Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study" Vaccines 14, no. 2: 146. https://doi.org/10.3390/vaccines14020146

Leroux-Roels, I., Day, T. A., Deleu, S., McLean, C., Go, O., Davies, T. A., Stoop, J. N., Peeters, M., Pau, M. G., Spiessens, B., Sarnecki, M., Cohen, K. A., & on behalf of E.ngage Study Team. (2026). Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines, 14(2), 146. https://doi.org/10.3390/vaccines14020146